Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02638493 · ClinicalTrials.gov registry record
The Compartmental Biology of HIV in the Male Genital Tract
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 26
- Enrollment target
NCT02638493 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 26 participants.
The verdict
NCT02638493 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Male participants taking tenofovir-emtricitabine (TDF/FTC) will provide semen and blood samples which will be analyzed to better understand the pharmacology of antiretroviral therapy in the male genital tract.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02638493
The ClinicalTrials.gov registry entry for NCT02638493 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02638493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02638493 about?
NCT02638493 is a clinical study titled "The Compartmental Biology of HIV in the Male Genital Tract". Male participants taking tenofovir-emtricitabine (TDF/FTC) will provide semen and blood samples which will be analyzed to better understand the pharmacology of antiretroviral therapy in the male genital tract.
What is the current status of trial NCT02638493?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2015-12. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT02638493?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.